Intellectual Property India Publishes Patent Application for 'Dosing Of Orexin Type 2 Receptor Agonists' Filed by Takeda Pharmaceutical Company Limited

MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517048766 A) filed by Takeda Pharmaceutical Company Limited, Osaka, Japan, on May 20, for 'dosing of orexin type 2 receptor agonists.'

Inventor(s) include Kimura, Haruhide; and Hara, Hiroe.

The application for the patent was published on June 6, under issue no. 23/2025.

According to the abstract released by the Intellectual Property India: "Disclosed are uses of an orexin type 2 receptor (OX2R) agonist at non-awakening concentrations. Also disclosed are compositions and methods for administering an OX2R agonist to a subject (e.g., mammal) in need thereof at a dose that provides a blood plasma concentration of the OX2R agonist that is at or below t...